Cargando…
A2M is a potential core gene in intrahepatic cholangiocarcinoma
BACKGROUND: Intrahepatic cholangiocarcinoma (ICC) is a type of malignant tumor ranking the second in the incidence of primary liver cancer following hepatocellular carcinoma. Both the morbidity and mortality have been increasing in recent years. Small duct type of ICC has potential therapeutic targe...
Autores principales: | Zhang, Guanran, Liu, Xuyue, Sun, Zhengyang, Feng, Xiaoning, Wang, Haiyan, Hao, Jing, Zhang, Xiaoli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722218/ https://www.ncbi.nlm.nih.gov/pubmed/34979994 http://dx.doi.org/10.1186/s12885-021-09070-2 |
Ejemplares similares
-
CHST4 might promote the malignancy of cholangiocarcinoma
por: Zhang, Guanran, et al.
Publicado: (2022) -
M2 macrophage inhibits the antitumor effects of Lenvatinib on intrahepatic cholangiocarcinoma
por: Yang, Long, et al.
Publicado: (2023) -
Integration analysis of miRNA–mRNA expression exploring their potential roles in intrahepatic cholangiocarcinoma
por: Liu, Liyan, et al.
Publicado: (2023) -
Diabetes and PKM2 affect prognosis in patients with intrahepatic cholangiocarcinoma
por: Fu, Kui, et al.
Publicado: (2020) -
Intrahepatic Sarcomatoid Cholangiocarcinoma
por: Malhotra, Shalini, et al.
Publicado: (2010)